| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |